Download PDF
Thromb Haemost 2012; 108(03): 416-418
DOI: 10.1160/TH12-08-0558
Theme Issue Editorial
Schattauer GmbH

Vessel wall – where coagulation meets cell biology and immunology

Tomasz J. Guzik
1   Translational Medicine Laboratory, Department of Internal and Agricultural Medicine, Jagiellonian University School of Medicine, Krakow, Poland
,
Jozef Dulak
2   Department of Medical Biotechnology, Jagiellonian University, Krakow, Poland
› Author Affiliations
Further Information

Publication History

Received: 03 August 2012

Accepted: 07 August 2012

Publication Date:
25 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Lutgens E, Binder CJ. Immunology of atherosclerosis. Thromb Haemost 2011; 106: 755-756.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-325.
    CrossrefPubMedGoogle Scholar
  • 3 Fish RJ, Neerman-Arbez M. Fibrinogen gene regulation. Thromb Haemost 2012; 108: 419-426.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Fish RJ, Neerman-Arbez M. A novel regulatory element between the human FGA and FGG genes. Thromb Haemost 2012; 108: 427-434.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Martin-Ventura JL, Madrigal-Matute J, Martinez-Pinna R. et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options. Thromb Haemost 2012; 108: 435-442.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Matusik P, Guzik B, Weber C. et al. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?. Thromb Haemost 2012; 108: 443-456.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Satta J, Laara E, Juvonen T. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm. J Vasc Surg 1996; 23: 737-739.
    CrossrefPubMedGoogle Scholar
  • 8 Yla-Herttuala S, Bentzon JF, Daemen M. et al. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost 2011; 106: 1-19.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Schramm A, Matusik P, Osmenda G. et al. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 2012; 56: 216-231.
    CrossrefPubMedGoogle Scholar
  • 10 Flierl U, Schafer A. Fractalkine - a local inflammatory marker aggravating platelet activation at the vulnerable plaque. Thromb Haemost 2012; 108: 457-463.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Lucas AD, Bursill C, Guzik TJ. et al. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemo-taxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 2003; 108: 2498-2504.
    CrossrefPubMedGoogle Scholar
  • 12 Wojakowski W, Tendera M, Cybulski W. et al. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxyge-nase-1 on the myocardial reperfusion injury. Thromb Haemost 2012; 108: 464-475.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Grochot-Przeczek A, Dulak J, Jozkowicz A. Heme oxygenase-1 in neovascularisation: A diabetic perspective. Thromb Haemost 2010; 104: 424-431.
    Article in Thieme ConnectPubMedGoogle Scholar